Differential Diagnosis of Frontotemporal Dementia, Alzheimer's Disease, and Normal Aging Using a Multi-Scale Multi-Type Feature Generative Adversarial Deep Neural Network on Structural Magnetic Resonance Images.
Source check: Source checked. Not independent scientific confirmation.
Finding: The study reports diagnostic classification performance against clinical diagnoses in its imaging cohort. Performance is cohort- and label-specific; independent prospective clinical validation is not established.
Technology: A multiscale, multi-type feature generative adversarial deep network classified structural MRI scans as frontotemporal dementia, Alzheimer disease or normal aging.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A multiscale, multi-type feature generative adversarial deep network classified structural MRI scans as frontotemporal dementia, Alzheimer disease or normal aging.
- Test and result
- The study reports diagnostic classification performance against clinical diagnoses in its imaging cohort.
- Limitation / still unknown
- Performance is cohort- and label-specific; independent prospective clinical validation is not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00853/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.